Fiche du document
11 mars 2022
- doi: 10.1126/sciadv.abm2536
- issn: 2375-2548
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciadv.abm2536
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35275719
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2375-2548
Ce document est lié à :
info:eu-repo/grantAgreement/SNF/Projects/310030_204679///
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_9AD2F453F4AF8
info:eu-repo/semantics/openAccess , CC BY-NC 4.0 , https://creativecommons.org/licenses/by-nc/4.0/
Mots-clés
MultidisciplinarySujets proches
Structures Edifices HallsCiter ce document
M. Kschonsak et al., « Structural basis for HCMV Pentamer receptor recognition and antibody neutralization. », Serveur académique Lausannois, ID : 10.1126/sciadv.abm2536
Métriques
Partage / Export
Résumé
Human cytomegalovirus (HCMV) represents the viral leading cause of congenital birth defects and uses the gH/gL/UL128-130-131A complex (Pentamer) to enter different cell types, including epithelial and endothelial cells. Upon infection, Pentamer elicits the most potent neutralizing response against HCMV, representing a key vaccine candidate. Despite its relevance, the structural basis for Pentamer receptor recognition and antibody neutralization is largely unknown. Here, we determine the structures of Pentamer bound to neuropilin 2 (NRP2) and a set of potent neutralizing antibodies against HCMV. Moreover, we identify thrombomodulin (THBD) as a functional HCMV receptor and determine the structures of the Pentamer-THBD complex. Unexpectedly, both NRP2 and THBD also promote dimerization of Pentamer. Our results provide a framework for understanding HCMV receptor engagement, cell entry, antibody neutralization, and outline strategies for antiviral therapies against HCMV.